274 related articles for article (PubMed ID: 17394949)
1. Cytosine deaminase/5-fluorocytosine exposure induces bystander and radiosensitization effects in hypoxic glioblastoma cells in vitro.
Chen JK; Hu LJ; Wang D; Lamborn KR; Deen DF
Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1538-47. PubMed ID: 17394949
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia response element-driven cytosine deaminase/5-fluorocytosine gene therapy system: a highly effective approach to overcome the dynamics of tumour hypoxia and enhance the radiosensitivity of prostate cancer cells in vitro.
Marignol L; Foley R; Southgate TD; Coffey M; Hollywood D; Lawler M
J Gene Med; 2009 Feb; 11(2):169-79. PubMed ID: 19051213
[TBL] [Abstract][Full Text] [Related]
3. Development of a hypoxia-inducible cytosine deaminase expression vector for gene-directed prodrug cancer therapy.
Wang D; Ruan H; Hu L; Lamborn KR; Kong EL; Rehemtulla A; Deen DF
Cancer Gene Ther; 2005 Mar; 12(3):276-83. PubMed ID: 15650767
[TBL] [Abstract][Full Text] [Related]
4. Monitoring gene therapy with cytosine deaminase: in vitro studies using tritiated-5-fluorocytosine.
Haberkorn U; Oberdorfer F; Gebert J; Morr I; Haack K; Weber K; Lindauer M; van Kaick G; Schackert HK
J Nucl Med; 1996 Jan; 37(1):87-94. PubMed ID: 8544010
[TBL] [Abstract][Full Text] [Related]
5. Fractionated radiation therapy in combination with adenoviral delivery of the cytosine deaminase gene and 5-fluorocytosine enhances cytotoxic and antitumor effects in human colorectal and cholangiocarcinoma models.
Stackhouse MA; Pederson LC; Grizzle WE; Curiel DT; Gebert J; Haack K; Vickers SM; Mayo MS; Buchsbaum DJ
Gene Ther; 2000 Jun; 7(12):1019-26. PubMed ID: 10871750
[TBL] [Abstract][Full Text] [Related]
6. Cytosine deaminase-producing human mesenchymal stem cells mediate an antitumor effect in a mouse xenograft model.
You MH; Kim WJ; Shim W; Lee SR; Lee G; Choi S; Kim DY; Kim YM; Kim H; Han SU
J Gastroenterol Hepatol; 2009 Aug; 24(8):1393-400. PubMed ID: 19486256
[TBL] [Abstract][Full Text] [Related]
7. Suicide gene therapy with the yeast fusion gene cytosine deaminase/uracil phosphoribosyltransferase is not enough for pancreatic cancer.
Fogar P; Navaglia F; Basso D; Greco E; Zambon CF; Fadi E; Falda A; Stranges A; Vannozzi F; Danesi R; Pedrazzoli S; Plebani M
Pancreas; 2007 Oct; 35(3):224-31. PubMed ID: 17895842
[TBL] [Abstract][Full Text] [Related]
8. Intratumoral 5-fluorouracil produced by cytosine deaminase/5-fluorocytosine gene therapy is effective for experimental human glioblastomas.
Miller CR; Williams CR; Buchsbaum DJ; Gillespie GY
Cancer Res; 2002 Feb; 62(3):773-80. PubMed ID: 11830532
[TBL] [Abstract][Full Text] [Related]
9. CEA-negative glioblastoma and melanoma cells are sensitive to cytosine deaminase/5-fluorocytosine therapy directed by the carcinoembryonic antigen promoter.
Dabrowska A; Szary J; Kowalczuk M; Szala S; Ugorski M
Acta Biochim Pol; 2004; 51(3):723-32. PubMed ID: 15448734
[TBL] [Abstract][Full Text] [Related]
10. Virally directed cytosine deaminase/5-fluorocytosine gene therapy enhances radiation response in human cancer xenografts.
Hanna NN; Mauceri HJ; Wayne JD; Hallahan DE; Kufe DW; Weichselbaum RR
Cancer Res; 1997 Oct; 57(19):4205-9. PubMed ID: 9331076
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and the bystander effect in CD::UPRT/5-FC bi-gene therapy of glioma.
Shi DZ; Hu WX; Li LX; Chen G; Wei D; Gu PY
Chin Med J (Engl); 2009 Jun; 122(11):1267-72. PubMed ID: 19567135
[TBL] [Abstract][Full Text] [Related]
12. Adenovirus mediated cytosine deaminase gene transduction and 5-fluorocytosine therapy sensitizes mouse prostate cancer cells to irradiation.
Anello R; Cohen S; Atkinson G; Hall SJ
J Urol; 2000 Dec; 164(6):2173-7. PubMed ID: 11061950
[TBL] [Abstract][Full Text] [Related]
13. A phase I trial of genetically modified Salmonella typhimurium expressing cytosine deaminase (TAPET-CD, VNP20029) administered by intratumoral injection in combination with 5-fluorocytosine for patients with advanced or metastatic cancer. Protocol no: CL-017. Version: April 9, 2001.
Cunningham C; Nemunaitis J
Hum Gene Ther; 2001 Aug; 12(12):1594-6. PubMed ID: 11529249
[TBL] [Abstract][Full Text] [Related]
14. In vivo preclinical low-field MRI monitoring of tumor growth following a suicide-gene therapy in an orthotopic mice model of human glioblastoma.
Breton E; Goetz C; Kintz J; Accart N; Aubertin G; Grellier B; Erbs P; Rooke R; Constantinesco A; Choquet P
C R Biol; 2010 Mar; 333(3):220-5. PubMed ID: 20338540
[TBL] [Abstract][Full Text] [Related]
15. Radiosensitization by 5-fluorocytosine of human colorectal carcinoma cells in culture transduced with cytosine deaminase gene.
Khil MS; Kim JH; Mullen CA; Kim SH; Freytag SO
Clin Cancer Res; 1996 Jan; 2(1):53-7. PubMed ID: 9816090
[TBL] [Abstract][Full Text] [Related]
16. Bystander effect caused by cytosine deaminase gene and 5-fluorocytosine in vitro is substantially mediated by generated 5-fluorouracil.
Kuriyama S; Masui K; Sakamoto T; Nakatani T; Kikukawa M; Tsujinoue H; Mitoro A; Yamazaki M; Yoshiji H; Fukui H; Ikenaka K; Mullen CA; Tsujii T
Anticancer Res; 1998; 18(5A):3399-406. PubMed ID: 9858915
[TBL] [Abstract][Full Text] [Related]
17. Enzyme/prodrug gene therapy for human colon cancer cells using adenovirus-mediated transfer of the Escherichia coli cytosine deaminase gene driven by a CAG promoter associated with 5-fluorocytosine administration.
Koyama F; Sawada H; Fujii H; Hirao T; Ueno M; Hamada H; Nakano H
J Exp Clin Cancer Res; 2000 Mar; 19(1):75-80. PubMed ID: 10840940
[TBL] [Abstract][Full Text] [Related]
18. Osteoclasts direct bystander killing of cancer cells in vitro.
Ramnaraine M; Pan W; Clohisy DR
Bone; 2006 Jan; 38(1):4-12. PubMed ID: 16139579
[TBL] [Abstract][Full Text] [Related]
19. Cytosine deaminase suicide gene therapy for peritoneal carcinomatosis.
Bentires-Alj M; Hellin AC; Lechanteur C; Princen F; Lopez M; Fillet G; Gielen J; Merville MP; Bours V
Cancer Gene Ther; 2000 Jan; 7(1):20-6. PubMed ID: 10678352
[TBL] [Abstract][Full Text] [Related]
20. Cytosine deaminase and thymidine kinase gene therapy in a Dunning rat prostate tumour model: absence of bystander effects and characterisation of 5-fluorocytosine metabolism with 19F-NMR spectroscopy.
Corban-Wilhelm H; Hull WE; Becker G; Bauder-Wüst U; Greulich D; Debus J
Gene Ther; 2002 Dec; 9(23):1564-75. PubMed ID: 12424609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
